miR-219 inhibits the proliferation, migration and invasion of medulloblastoma cells by targeting CD164

被引:28
|
作者
Shi, Jia-Ang [1 ]
Lu, Da-Lin [2 ]
Huang, Xuan [3 ]
Tan, Wei [2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Psychiat, Chengdu 610041, Sichuan, Peoples R China
[2] Wuhan Univ Sci & Technol, Tianyou Hosp, Wuhan 430081, Hubei, Peoples R China
[3] Nanchang Univ, Coll Med, Nanchang 330000, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
medulloblastoma; microRNA-219; CD164; OTX2; BREAST-CANCER CELLS; METASTASIS; EXPRESSION; PHENOTYPE; TUMOR;
D O I
10.3892/ijmm.2014.1749
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
It is known that microRNA-219 (miR-219) expression is downregulated in medulloblastoma. In the present study, we investigated the expression, targets and functional effects of miR-219 in D283-MED medulloblastoma cells. We first demonstrated that miR-219 not only inhibits proliferation, but also suppresses the invasion and migration of D283-MED cells. Moreover, the knockdown of miR-219 promoted the proliferation, migration and invasion of the D283-MED cells. Secondly, we predicted that miR-219 targets the 3' untranslated region (3'UTR) of CD164 and orthodenticle homeobox 2 (OTX2) and then confirmed that it significantly downregulated the protein expression of CD164 and OTX2 in D283-MED cells. Finally, we demonstrated that the proliferation, invasion and migration of D283-MED cells were promoted by theec-topic expression of CD164. These results indicate that miR-219 suppresses the proliferation, migration and invasion of medulloblastoma cells by targeting CD164. The results also suggest that miR-219 may serve as a potential therapeutic agent for medulloblastoma.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 50 条
  • [1] HOTAIR inhibits the proliferation of glioblastoma cells by targeting miR-219
    Li, Huixia
    Guan, Congjin
    CANCER BIOMARKERS, 2020, 28 (01) : 41 - 47
  • [2] miR-219 inhibits the growth and metastasis of TSCC cells by targeting PRKCI
    Song, Kai-Bin
    Liu, Wen-Juan
    Jia, Shen-Shan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (09): : 2957 - 2965
  • [3] CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma
    Tu, Ming
    Cai, Lin
    Zheng, Weiming
    Su, Zhipeng
    Chen, Yong
    Qi, Songtao
    MOLECULAR MEDICINE REPORTS, 2017, 15 (04) : 1713 - 1721
  • [4] miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164
    Wei, Tao
    Cheng, Shan
    Fu, Xiao Na
    Feng, Lian Jie
    BIOSCIENCE REPORTS, 2020, 40
  • [5] miR-219a-1 inhibits colon cancer cells proliferation and invasion by targeting MEMO1
    Xu, Keqing
    Shi, Jie
    Mo, Dongping
    Yang, Yanhua
    Fu, Qiang
    Luo, Ying
    CANCER BIOLOGY & THERAPY, 2020, 21 (12) : 1163 - 1170
  • [6] miR-4429 inhibits ccRCC proliferation, migration, and invasion by directly targeting CD274
    Hong, Guangyi
    Wu, Yikun
    Huang, Shiyu
    Hu, Yang
    Zhang, Ying
    Guo, Cici
    Shi, Hua
    Xu, Shuxiong
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [7] miR-877 inhibits the proliferation, migration, and invasion of osteosarcoma cells by targeting gamma-glutamylcyclotransferase
    Jia, Chenguang
    Gao, Jianguo
    Wang, Lianbo
    Li, Zhuo
    Dong, Zhaoliang
    Yao, Liming
    Yao, Xiaowei
    ENDOCRINE JOURNAL, 2021, 68 (09) : 1109 - 1116
  • [8] MiR-155 inhibits proliferation, invasion and migration of melanoma via targeting CBL
    Li, H.
    Song, J-B.
    Chen, H-X.
    Wang, Q-Q.
    Meng, L-X.
    Li, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (21) : 9525 - 9534
  • [9] MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT
    Li, Zhen
    Liu, Yun-hui
    Diao, Hong-yu
    Ma, Jun
    Yao, Yi-long
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 468 (04) : 870 - 876
  • [10] miR-145-5p Inhibits the Proliferation, Migration, and Invasion of Esophageal Carcinoma Cells by Targeting ABRACL
    Fan, Shengming
    Chen, Pei
    Li, Shugang
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021